
CMA Launches Public Consultation on New Investment Product for Parallel Market
The public consultation will remain open for 30 calendar days, concluding on 10/11/1446H (08/05/2025).
In its press release, the CMA stated that the draft proposal seeks to encourage private sector companies to go public via SPACs, helping to meet financing demands and deepen the capital market through a broader range of investment options.
The CMA stressed that all feedback will be carefully considered in finalizing the proposed amendments, which are intended to support the continued development of a robust and dynamic regulatory framework.
To share your comments, visit:
https://cma.org.sa/Market/News/pages/CMA_N_3779.aspx
Related Topics:
Saudi CMA Eases Nomu Investment Rules to Boost Market
CMA Seeks Public Feedback on Proposed Changes to Investor Categories in Parallel Market
Saudi Arabia's Life Expectancy Hikes to 78.8 Years in 2024
Saudi Arabia Allows Foreign Investment Mecca, Medina's Real Estate Companies
Short link :
Post Views: 11 Related Stories

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Argaam
3 hours ago
- Argaam
Signworld issues prospectus to float 1.5M shares on Nomu
National Signage Industrial Co. (Signworld) issued today, July 27, the prospectus to float 1.5 million shares, or 20% of capital, on the Nomu -Parallel Market. The company will offer 1.5 million shares, equal to 25% of pre-offering and 20% of post-offering capital, to qualified investors. For More IPOs The share sale will run from Aug. 17-24. The Capital Market Authority (CMA) approved, in March, the company's application for direct listing on Nomu. Signworld's core business involves the design, manufacturing, and assembly of electronic panels and displays for various applications, in addition to installation and maintenance services. It operates through three branches. Company Profile Company National Signage Industrial Co. (Signworld) Core Activities Manufacturing and sale of feed products Market Nomu-Parallel Market Pre-IPO Capital SAR 60mln Number of Shares 6 mln Post-IPO Capital SAR 75 mln New Number of Shares 7.5 mln Nominal Value SAR 10 a share IPO Summary Issue Percentage 20% of post-IPO capital, 25% of pre-IPO capital Offered Shares SAR 1.5 mln IPO Minimum Limit 10 shares IPO Maximum Limit 374,990 shares Offer Period Aug. 17-24, 2025 Final Allocation Aug. 27, 2025 Surplus Refund (If any) Aug. 31, 2025 Company Shareholders Shareholders Before IPO After IPO Number of Shares (mln) Ownership (%) Number of Shares (mln) Ownership (%) Al Mohandes Holding Group 6.00 100.00 % 6.00 80% Qualified investors -- -- 1.50 20% Total 6.00 100 % 7.50 100%


Argaam
4 hours ago
- Argaam
CMA to prioritize rated debt offerings under new incentive plan
The Capital Market Authority (CMA) approved a new incentive to fast-track public debt offering applications for issuers or instruments rated by a CMA-licensed credit agency, with the measure effective through end-2026. The CMA said the move aims to boost efficiency and transparency in the debt market, strengthen its role in business financing and growth, and encourage rated issuers to widen investor participation and deepen the market. The initiative supports the CMA's broader strategy to deepen the Saudi capital market, enhance transparency and appeal, and aligns with Vision 2030 goals to diversify funding sources and boost financial sustainability. The CMA stressed that credit ratings are more than creditworthiness indicators, they are essential tools for enabling investors to make informed decisions based on clearer risk assessments. By fast-tracking rated offerings, the CMA aims to develop a more stable and mature debt market, broaden the investor base, strengthen market confidence, and support better risk assessment of listed instruments. The CMA expects the move to ease corporate access to debt markets, boost issuance volume, and enhance offering appeal, noting that credit ratings help financial advisors market deals, particularly to institutional and qualified investors. Credit ratings provide forward-looking assessments of credit risk, indicating default likelihood and potential creditor losses. Issuers use them to demonstrate credit strength and attract investors, while investors rely on them for credit analysis and debt evaluation.


Argaam
5 days ago
- Argaam
Qomel sees continued demand growth, sets timetable for TASI transition: CEO
Hisham Al-Agla, CEO of Qomel Co. said that demand for the company's products has picked up during the first half of 2025, expecting demand to continue growing moving forward. In statements to Argaam, the top executive added that construction work on the new plant is more than 90% complete, with production likely to commence before the end of this year. He indicated that the new plant will directly impact sales growth over the next three years until it reaches full production capacity, highlighting that this will reflect positively on the company's revenues and profits. Al-Agla also stated that the increase in profit margins will occur gradually, as the plant incurred significant capital expenditures initially. 'It is unlikely that current profit margins will be maintained until the plant reaches full production capacity. However, within three or four years, this will begin to reflect positively on margins,' he added. Qomel is seeking to transition to the Main Market (TASI) and has already completed many of the requirements of the Capital Market Authority, said the top executive, noting that a timeline has been set for the transition and application submission, expecting the remaining procedures to be finalized by the beginning of next year. The company has obtained approval from the Saudi Food and Drug Authority to register a number of new products, which have contributed to a gradual increase in sales in the first half of this year. It has a large number of products under registration, and it is expected to obtain successive approvals to market these products during the second half of this year, according to the CEO. He further stated that the pharmaceutical market in the Kingdom is witnessing continuous growth, adding that the company is taking major steps towards keeping pace with this growth and boosting its market share through the sale and marketing of new products. The company's focus remains on the Saudi market at this stage, but it has strategic goals to enter new markets in the region through products that will be manufactured locally once the plant is operational, Al-Agla said. According to data available with Argaam, Qomel's profits rose to SAR 11.8 million during H1 2025, an 8% increase compared to SAR 11 million during the same period in 2024.